Evaluating the Translation Value of Two In Vivo Models for Breast Cancer Brain Metastases
Cancers · 27.03.2026 · 18 (7) · 1095
DOI: 10.3390/cancers18071095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 27.03.2026. Verfasst von Sigrid Cold und 8 weiteren Autor:innen. Beteiligte Einrichtung: Minerva Imaging ApS, 3650 Ølstykke, Denmark. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovation Foundation Denmark.
Abstract (Originalsprache)
Background
Breast cancer brain metastases (BCBM) lack effective treatments, contributing to breast cancer-related morbidity and mortality. Integrating translational animal models and advanced non-invasive imaging can accelerate the development of urgently needed therapies.
Method
In this study, we developed an intracarotid method mimicking BCBM and compared it to the stereotactic model in terms of animal welfare, tumour establishment, and blood–brain barrier (BBB) permeability. BCBM was established through intracarotid or stereotactic inoculation of BT474 and MDA-MB-231.Luc2 cells in NMRI nude mice. We utilised magnetic resonance imaging (MRI) and bioluminescence imaging (BLI) to monitor tumour growth and BBB permeability, supported by fluorescent immunohistochemistry for validation. Finally, light sheet microscopy (LSM) was employed to visualise tumour establishment in intact brains.
Results
Both inoculation methods achieved a survival rate > 70%, with animals recovering within a week post-surgery. MRI and BLI effectively visualised tumour growth with stereotactic implantation, resulting in single tumours, while intracarotid inoculation led to micro-seeding of up to seven tumours in one brain. Tumour growth was rapid and homogenous in the stereotactic model, whereas the intracarotid model exhibited slower, heterogenous growth. Notably, BBB permeability was significantly higher in small tumours in the stereotactic model when compared to the intracarotid model (p = 0.003). Ex vivo analyses validated these findings with the identification of multiple metastasis in the intracarotid model and single tumours in the stereotactic model.
Conclusions
We developed an animal model that closely mimics BCBM, highlighting extravasation and micro-seeding while maintaining animal welfare. Our established imaging protocols enable longitudinal evaluations of BBB permeability and treatment response, creating a translational platform for testing novel anti-cancer therapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Minerva Imaging ApS, 3650 Ølstykke, Denmark.
- Cluster for Molecular Imaging, Department of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
- Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital, Rigshospitalet, 2100 Copenhagen, Denmark.
ORCID-Profile: Andreas Kjaer
Förderung
- Innovation Foundation Denmark
Zitieren
APA
Cold, S., Alfsen, M. Z., Halgirsson, B., Jorgensen, M. N., Hald, J., Nielsen, C. H., Kjaer, A., Kristensen, L. K., & Engel, T. B. (2026). Evaluating the Translation Value of Two In Vivo Models for Breast Cancer Brain Metastases. Cancers, 18(7), 1095. https://doi.org/10.3390/cancers18071095
Vancouver
Cold S, Alfsen MZ, Halgirsson B, Jorgensen MN, Hald J, Nielsen CH, et al. Evaluating the Translation Value of Two In Vivo Models for Breast Cancer Brain Metastases. Cancers. 2026;18(7):1095. doi:10.3390/cancers18071095
BibTeX
@article{Cold2026,
author = {Cold, Sigrid and Alfsen, Maria Zeiler and Halgirsson, Brandur and Jorgensen, Mads Neergaard and Hald, Jacob and Nielsen, Carsten Haagen and Kjaer, Andreas and Kristensen, Lotte Kellemann and Engel, Trine Bjornbo},
title = {Evaluating the Translation Value of Two In Vivo Models for Breast Cancer Brain Metastases},
journal = {Cancers},
year = {2026},
volume = {18},
number = {7},
pages = {1095},
doi = {10.3390/cancers18071095}
}
EUVIMED